SCHEMBL9880213

SCHEMBL9880213

CC(=O)OCC1OC(OCC2OC(OCC3OC(OCC4OC(C)C(OC(=O)c5ccccc5)C(C)C4C)C(OC(=O)c4ccccc4)C(C)C3C)C(OC(=O)c3ccccc3)C(C)C2C)C(OC(=O)c2ccccc2)C(C)C1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
TSHR P16473 1/20 0.43
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.37
USP2 O75604 1/20 0.37
POLB P06746 1/20 0.37
LGALS9 O00182 1/20 0.37
LGALS1 P09382 1/20 0.37
LGALS3 P17931 1/20 0.37
LGALS7; LGALS7B P47929 1/20 0.37
P4HB P07237 1/20 0.37
PDIA4 P13667 1/20 0.37
PDIA3 P30101 1/20 0.37
PTPN1 P18031 1/20 0.36
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA4 P22748 2/20 0.36
CA5A P35218 2/20 0.36
CA7 P43166 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9880214 0.90 LMNA (0.42) LMNATSHRKMT2AMEN1USP2
SCHEMBL9880217 0.89 LGALS3 (0.38) KMT2AMEN1USP2POLBLGALS9
SCHEMBL9880223 0.89 LGALS3 (0.38) KMT2AMEN1USP2POLBLGALS9
SCHEMBL9880221 0.89 LGALS3 (0.46) LGALS9LGALS1LGALS3LGALS7; LGALS7BSELP
SCHEMBL16768979 0.88 USP2 (0.42) KMT2AMEN1USP2POLBLGALS9
SCHEMBL17885820 0.86 LMNA (0.43) LMNATSHRKMT2AMEN1USP2
SCHEMBL9880212 0.85 LGALS3 (0.40) KMT2AMEN1USP2POLBLGALS9
SCHEMBL16360807 0.84 TSHR (0.47) LMNATSHRKMT2AMEN1USP2
SCHEMBL16768969 0.83 PTPN1 (0.47) KMT2AMEN1USP2POLBLGALS9
SCHEMBL18067737 0.82 PTPN1 (0.53) KMT2AMEN1USP2POLBLGALS9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8883170-B2 Adjuvant WESTERN ILLINOIS UNIVERSITY RESEARCH FOUNDATION (US) 2014-11-11 US disclosed
US-20120136142-A1 Vaccine Compositions For Marburg Virus SOUTHERN RESEARCH INSTITUTE (US) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136142-A1 Vaccine Compositions For Marburg Virus OSBPL3, OSBP2, CD81 LMNA 3165/4885TSHR 4175/4885KMT2A 4584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.